Maine’s marijuana czar says launching the adult-use industry by June is ‘simply unrealistic.’
The coronavirus pandemic has compelled Maine to put its planned June debut of the state’s long-awaited recreational cannabis market on indefinite hold.
“It now appears as though a spring launch of Maine’s adult use industry is simply unrealistic,” said Erik Gundersen, the director of the Maine Office of Marijuana Policy. “Public health experts have clearly communicated that they cannot answer what social distancing or other guidance may be in effect as we approach late spring and early summer.”
The pandemic also has forced local communities likely to host the industry’s first growing operations, processing labs, retail stores and testing labs to postpone authorizing these activities, Gundersen noted. Under state law, all recreational products must be tested for potency and safety before sales can occur.
Kennebunk was set to hold an April 7 referendum on whether to allow Nelson Analytical, a local lab that already tests medical marijuana, to begin testing recreational cannabis, too, but had to push that vote off until May because of the pandemic. Nelson was the first lab to apply for a state marijuana testing license. [Read More @ Portland Press Herald]
Your email address will not be published. Required fields are marked *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.
Comment *
Notify me of follow-up comments by email.
Notify me of new posts by email.
Δ
Advocates of legalizing recreational marijuana in South Dakota, a mission with a rocky history, submitted thousands of signatures to election officials on Tuesday in the hopes of once again getting…
Founded in 2018, Michigan-based C3 Industries is a privately owned, vertically integrated cannabis company that has in short order expanded its retail, cultivation, and manufacturing operations from one state to…
By Aaron Pelley, Attorney at Harris Sliwoski The fluctuating levels of reported THC (tetrahydrocannabinol) in cannabis products have sparked discussions and concerns within the industry. Contrary to popular belief, the…
The Biden administration is expected to reclassify the federal government’s position on marijuana, shifting it from a Schedule I drug to a Schedule III drug, The Associated Press first reported. The change would…